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Abstract
Background: Clinical symptoms of affective disorders, their response to light treatment, and
sensitivity to other circadian interventions indicate that the circadian system has a role in mood
disorders. Possibly the mechanisms involve circadian seasonal and photoperiodic mechanisms.
Since genetic susceptibilities contribute a strong component to affective disorders, we explored
whether circadian gene polymorphisms were associated with affective disorders in four
complementary studies.
Methods: Four groups of subjects were recruited from several sources: 1) bipolar proband-parent
trios or sib-pair-parent nuclear families, 2) unrelated bipolar participants who had completed the BALM
morningness-eveningnessquestionnaire,3)sibpairsfromtheGenRedProjecthavingatleastonesibwith
early-onset recurrent unipolar depression, and 4) a sleep clinic patient group who frequently suffered
from depression. Working mainly with the SNPlex assay system, from 2 to 198 polymorphisms in genes
related to circadian function were genotyped in the participant groups. Associations with affective
disorders were examined with TDT statistics for within-family comparisons. Quantitative trait
associations were examined within the unrelated samples.
Results: In NR1D1, rs2314339 was associated with bipolar disorder (P = 0.0005). Among the
unrelated bipolar participants, 3 SNPs in PER3 and CSNK1E were associated with the BALM score.
A PPARGC1B coding SNP, rs7732671, was associated with affective disorder with nominal
significance in bipolar family groups and independently in unipolar sib pairs. In TEF, rs738499 was
associated with unipolar depression; in a replication study, rs738499 was also associated with the
QIDS-SR depression scale in the sleep clinic patient sample.
Conclusion: Along with anti-manic effects of lithium and the antidepressant effects of bright light,
these findings suggest that perturbations of the circadian gene network at several levels may
influence mood disorders, perhaps ultimately through regulation of MAOA and its modulation of
dopamine transmission. Twenty-three associations of circadian polymorphisms with affective
symptoms met nominal significance criteria (P < 0.05), whereas 15 would be expected by chance,
indicating that many represented false discoveries (Type II errors). Some evidence of replication
has been gathered, but more studies are needed to ascertain if circadian gene polymorphisms
contribute to susceptibility to affective disorders.
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The idea that circadian rhythms had some role in
affective disorders arose from clinical observations of
their altered sleep-wake cycles, the cyclicity of the
symptoms, and early work by pioneering researchers
[1-4]. Attempts to identify circadian abnormalities in
depressed and bipolar patients by physiologic means
have yielded somewhat inconsistent and disappointing
results [5-7]. However, the now-proven efficacy of bright
light treatment as well as a broader range of effective
interventions in the circadian system provide strong
evidence that circadian rhythms are somehow involved
in the pathophysiology of affective disorders [8].
The effects of light treatment, along with the symptom
development of seasonal affective disorder (often a
bipolar phenotype), might suggest that mechanisms
which trigger mood swings in humans resemble the
circadian-controlled photoperiodic mechanisms govern-
ing mammalian seasonality [9]. Recently, a number of
studies of nocturnal and diurnal rodents have demon-
strated influences of photoperiod upon animal models
of depression [10-12]. Several reports have presented
rationales and preliminary suggestive evidence that
circadian system genetic abnormalities might contribute
to affective disorders [13-18]. In addition, accumulating
evidence indicates that heritable circadian disorders such
as delayed sleep phase disorder are comorbid with
depression [19]. This may suggest that there are genetic
polymorphisms in the circadian system which confer
susceptibility both to depression and to delayed sleep
phase disorder or its converse, advanced sleep phase
disorder.
Genome-wide association studies of bipolar disorder
have given no substantial support for a role of the
circadian system [20, 21], although in one study,
VGCNL1, a gene which may have a circadian role,
came close to genome-wide significance [22]. Genome-
wide studies, however, are designed to detect common
allelic variants of small effect, and do not exclude other
t y p e so fg e n ee f f e c t s ,s u c ha sr a r ev a r i a n t so fs t r o n ge f f e c t .
Though the genome-wide association method may
eventually replace the testing of candidate genes, we
have thought it worthwhile to survey likely single
nucleotide polymorphisms (SNPs) in the set of genes
w h i c hf o r mt h ec i r c a d i a ns y s t e mt h r o u g hc o m p l e x
interactions. Most of the SNPs we have considered
have not been tested directly in whole-genome associa-
tion studies. Moreover, in some models, we have used
transmission disequilibrium tests (TDT) with parent-
proband trios or affected sib pairs which eliminate
population stratification as a potential source of false-
negative results. Here we report results of 4 ongoing
studies which provide some cross-replication, and taken
together, suggest that several circadian polymorphisms
are associated with phenotypes related to affective
disorders.
Methods
We describe 4 complementary studies, assembled to
provide replication and to clarify what aspects of
circadian polymorphisms may be relevant to both
bipolar and unipolar affective disorders.
Bipolar probands and families
From probands with bipolar disorder, DNA samples
from 444 nuclear families were assembled including 561
affected offspring. These were largely proband-parent
trios or affected sib pairs with parents. These nuclear
families were obtained primarily from two different
samples. The first was a set of families collected as part of
a three site consortium (UCSD, U. Cincinnati, and U.
British Columbia) for linkage studies in extended
pedigrees. The remainder of the families came from
waves 1–4o ft h eN I M HG e n e t i c sI n itiative for Bipolar
Disorder Collection. Both family sets and the ascertain-
ment and diagnostic methods employed have been
described in detail elsewhere [23, 24]. For this analysis,
we included bipolar type 1 disorder, bipolar type 2
disorder, and schizoaffective (bipolar type) patients as
affected participants. Although the TDT is not subject to
an increased type one error rate due to population
stratification, only self-identified Caucasians were
included in this analysis.
Single-nucleotide polymorphisms were assayed with 6
reagent pools targeting 45–48 SNPs, using the SNPlex™
Genotyping System with an ABI 3730 48-capillary DNA
analyzer according to the manufacturer's directions
(Applied Biosystems, Foster City, California). Techni-
cally satisfactory genotypes with sufficient heterozygosity
for analysis were obtained for 197 SNPs [see Additional
file 1]. In addition, a polymorphic repeat region with
four or five copies of a 54 bp repetitive sequence in exon
18 of the PER3 gene was examined [25, 26]. PCR of the
polymorphic area was performed using the primers:
6-FAM AGGCAACAATGGCAGTGAG fluorescently
labeled, and Rev AATGTCTGGCATTGGAGTTTG. Pro-
ducts of 309 bp and 363 bp were distinguished by gel
electrophoresis, using the 6-Fam fluorescent label on the
forward primer to determine fragment size. PLINK v1.03
[ 2 7 ]w a su s e dt ot e s tf o rH W E ,a n dt r a n s m i s s i o n
disequilibrium from parent to affected child was tested
using a transmission-disequilibrium test (TDT). Empiri-
cal p-values were generated using the max(T) permuta-
tion approach for pointwise estimates (EMP1) as well as
corrected for all comparisons (EMP2). Compared to a
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isons, a global permutation test is a more powerful
approach for candidate gene studies as it considers the
correlation structure between SNPs in LD with each
other. Correlation between SNPs (LD structure) was
assessed with HaploView 4.1. (Broad Institute, Cam-
bridge, MA).
Bipolar probands and the morningness-eveningness
quantitative trait
A group of 130 unrelated research volunteers completed
the Basic Language Morningness (BALM) Scale, a 13-
item multiple-choice questionnaire designed to distin-
guish participants with high, normal, or low "morning-
ness" [28]. These subjects were recruited at UCSD for
genetic studies of bipolar disorder, but they were not
primarily parts of family groups and only 5 were also
included in the TDT family sample. Of the 130 subjects
with available BALM data, according to research diag-
noses, 82% were Bipolar Type I (not necessarily manic at
the time), 3 had had unipolar major depression, one was
schizoaffective, and the rest had no psychiatric diagnosis.
T h o s ew i t hh i g hB A L Ms c o r e st e n dt og ot ob e de a r l ya n d
arise early: in the extreme, they may suffer from
advanced sleep phase disorder. Those with low BALM
scores tend to go to bed late and to arise late in the
morning: with extremely low scores, they may suffer
from delayed sleep phase disorder. This quantitative
trait, thought to reflect control by circadian "clock"
genes, is roughly 50% heritable [29-31]. The 6th (most
recent) SNPlex™ pool was assayed for each participant,
but the other assay reagent pools were not available. Of
the 48 SNPs in the pool, 44 were successfully assayed
and 30 passed quality control. With PLINK [27],
quantitative trait associations (additive model) were
performed and empirical p-values estimated based on
the Wald-statistic (t-distribution). To correct for popula-
tion stratification, subjects were grouped into self-
identified Caucasians (n = 95) and others (n = 35) and
permutations were performed within these two groups
using the max(T) permutation approach for pointwise
estimates (EMP1) as well as corrected for multiple
comparisons (EMP2).
Unipolar major depression affected sibling pairs
Families with probands with recurrent early-onset uni-
polar depression were recruited by the GenRED project
[32]. These subjects were ascertained as part of a multi-
site consortium to conduct linkage studies of major
depression, and diagnoses made using a standardized
best estimate method as previously described. Through
the National Institute of Mental Health Human Genetics
Initiative, DNA from 150 GenRED sibling pairs with at
least one affected sibling was kindly supplied by the
Rutgers University Cell & DNA Repository. These
samples were also assayed with SNPlex pools 5 and 6
(88 SNPs), resulting in high-quality genotypes of 63
SNPs. Using PLINK, family-based sib-TDT (DFAM)
analyses were computed including 298 individuals in
149 families (89 concordant and 60 discordant sib-
pairs). As in the other analyses, empirical p-values were
generated using the max(T) permutation approach for
pointwise estimates (EMP1) as well as corrected for
multiple comparisons (EMP2). To safeguard against
spurious associations due to population stratification, a
TDT was used in this sample approximately 95% of
European origin [32].
Sleep Clinic sample
Patients of the Scripps Clinic Sleep Center who under-
went polysomnography or some other form of sleep
recording were invited to participate in a descriptive
genetic study. They consented to contribute saliva DNA
samples and a research questionnaire, which included
the BALM morningness-eveningness scale and the QIDS-
SR self-rated depression scale [33]. This sample was 90%
Caucasian by self-report. DNA was extracted and
genotyped for 360 participants in the DNA Core
Laboratory of the Molecular and Experimental Medicine
division of the Scripps Research Institute. The alleles of
rs2314339 and rs738499 were identified by allele-
specific oligonucleotide hybridization [34].
Ethical guidelines
Since the DNA samples were collected from many
sources, the original publications should be consulted
for information concerning institutional review boards.
I ng e n e r a l ,t h ed a t aw e r ec o l l e c t e di na c c o r dw i t ht h e
principles of the Declaration of Helsinki.
Results
Transmission disequilibrium in families of bipolar
probands
Of approximately 260 SNPs assayed in the SNPlex pools
or by gel electrophoresis, 212 polymorphisms were
successfully genotyped. Of these, 198 polymorphisms
yielded polymorphic genotypes of acceptable quality
[see Additional file 1]. The TDT was applied to these
polymorphisms, located in or near 26 genes associated
with the circadian system. As shown in Table 1, 17
polymorphisms had nominal P values < 0.05, modestly
exceeding the random expectation of 10 of 198
polymorphisms.
The strongest association with bipolar disease was found
with NR1D1 (Rev-erb-alpha, OMIM 602408). Using a
permutation procedure to correct for multiple compar-
isons, rs2314339, an intronic SNP, showed a significant
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P(corrected) < 0.035). Using a false discovery rate thresh-
old of 5%, rs2314339 was significantly associated with
disease status (q-value < 0.05) [35]. In addition, two
SNPs within this gene and one SNP within the nearby
THRA were nominally significant (p < 0.05, Table 1). The
SNPs most strongly associated in this region were
moderately correlated with one another (pairwise
r-squared between rs2314339 and rs2071427 = 0.26;
rs2314339 and rs2269457 = 0.29; rs2314339 and
rs939348 = 0.27).
Suggestive evidence for association with bipolar disease
was also found for the CLOCK gene (OMIM 601851).
Thirteen SNPs were investigated in this gene, and six of
them were nominally significant by the EMP1 criterion,
the most significant being rs3805148 (p = 0.0092) and
rs12504300 (p = 0.0094) (Table 1). These 6 SNPs are all
in linkage disequilibrium (pairwise r-squared 0.23–0.99)
in a single 75 KB linkage block which covers almost all
the gene. They form a common, overtransmitted
haplotype with a frequency of 28.2 percent
(234.1:181.5 T:U, P(nominal) < 0.01). The often-discussed
T3111C SNP in the 3' UTR (rs1801260) [36, 37] was not
in close linkage disequilibrium with these 6 SNPs
(largest pairwise r-squared < 0.22), and it was not
significantly associated with bipolar disease (P > 0.69).
In addition, modest evidence for association to bipolar
disease was also found for PER2 (OMIM 603426) with 3 of
the 15 tested PER2 SNPs nominally significant (rs4663868:
p < 018, rs2304672: p < 0.013; pairwise r-squared = 0.93;
rs2304669: p < 0.042, not in LD with the other 2 SNPs).
SNPs associated with the BALM in bipolars
Of the SNPs in bipolars for whom BALM data were
available, 30 yielded acceptable genotypes which were
sufficiently polymorphic for analysis [see Additional file
2]. Of these, three relatively rare SNPs were associated
with BALM values with significance at a P < 0.05
criterion after correction for multiple comparison
(Table 2). Results for additive and dominant models
were similar, since there were few homozygotes of the
rare allele for these rare SNPs (data not shown).
The PER3 nonsynonymous coding SNP Ala856Pro
(rs228697) was associated with the BALM with R
2 =
0.091, P = 0.0008 in an additive model. The presence of
Table 1: Polymorphisms associated with bipolar disorder
Gene CHR SNP A1 A2 MAF T U OR CHISQ P EMP1 EMP2
NPAS2 2 rs1562313 A G 0.213 208 165 1.261 4.957 0.0260 0.0484 0.9803
PER2 2 rs4663868 T C 0.071 85 54 1.574 6.914 0.0086 0.0171 0.7330
PER2 2 rs2304669 G A 0.164 131 167 0.784 4.349 0.0370 0.0416 0.9945
PER2 2 rs2304672 G C 0.073 88 55 1.600 7.615 0.0058 0.0123 0.5972
CLOCK 4 rs3805148 C A 0.366 255 197 1.294 7.442 0.0064 0.0092 0.6291
CLOCK 4 rs3736544 A G 0.373 229 280 0.818 5.110 0.0238 0.0241 0.9728
CLOCK 4 rs12504300 C G 0.282 188 138 1.362 7.669 0.0056 0.0094 0.5775
CLOCK 4 rs4864542 G C 0.364 273 212 1.288 7.672 0.0056 0.0102 0.5759
CLOCK 4 rs12648271 C G 0.285 227 182 1.247 4.951 0.0261 0.0369 0.9806
CLOCK 4 rs6850524 C G 0.424 232 282 0.823 4.864 0.0274 0.0322 0.9840
PPARGC1B 5 rs7732671 C G 0.068 65 42 1.548 4.944 0.0262 0.0213 0.9811
PER1 17 rs2585405 G C 0.104 86 117 0.735 4.734 0.0296 0.0457 0.9881
THRA 17 rs939348 T C 0.279 188 239 0.787 6.091 0.0136 0.0224 0.8729
NR1D1 17 rs2314339 T C 0.130 90 147 0.612 13.710 0.0002 0.0005 0.0338
NR1D1 17 rs2071427 A G 0.256 191 256 0.746 9.452 0.0021 0.0019 0.2852
NR1D1 17 rs2269457 G A 0.239 171 214 0.799 4.803 0.0284 0.0292 0.9861
CSNK1D 17 rs4510078 A G 0.021 18 38 0.474 7.143 0.0075 0.0175 0.6942
GENE: NCBI gene symbol. CHR: chromosome number. SNP: dbSNP symbol. A1 & A2: minor and major allele nucleotides. MAF: minor allele
frequency. T: number of transmissions of the rare allele. U: number of untransmitted rare alleles. OR: odds ratio of TDT. CHISQ: Chi Square from
TDT. P: probability of Chi Square. EMP1: empirical probability from simulation by PLINK. EMP2: corrected empirical P (Max T/familywise).
Table 2: SNPs associated with the BALM among bipolar participants
Gene CHR SNP A1 A2 MAF BETA R2 EMP1 EMP2 genotype freq
PER3 1 rs228697 G C 0.083 -6.36 0.0913 0.0008 0.0150 4/15/110
CSNK1E 22 CSNK1E28266 A G 0.025 13.67 0.0785 0.0008 0.0467 0/5/119
CSNK1E 22 CSNK1E27740 T G 0.028 12.45 0.0753 0.0010 0.0506 0/6/121
CHR: chromosome. A1 & A2: minor and major allele nucleotides. MAF: minor allele frequency. R
2: the correlation squared. EMP1: pointwise
empirical P value. EMP2: corrected empirical P value from max/(T)/familywise.
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ness (i.e., a lower BALM morningness score): a mean
BALM of 26 for 4 homozygotes for the minor allele, a
mean BALM of 31 for 15 heterozygotes, and a mean
BALM of 38 for the 110 homozygotes with the common
allele. Although the genotypes barely failed Hardy-
Weinberg equilibrium (Pnominal < 0.04) in this popula-
tion, this SNP showed no deviation from HWE in the
simultaneously assayed bipolar TDT sample, indicating
good genotyping quality.
Two intronic SNPs in CSNK1E were associated with the
BALM with nominal P < 0.001 in an additive model,
associatedwithalmost8%ofthevariance.ThetwoSNPsare
526 nucleotides apart and essentially in perfect linkage
disequilibrium. For one subject, one of the linked SNPs
couldnotbegenotyped.ThemeanBALMscoreswere49–50
for heterozygotes (high morningness) and 36 for homo-
zygotes with the common allele. Four or 5 of the hetero-
zygotes had a BALM ≥ 50, the 95
th percentile, indicating
extreme morningness, but one had the minimum possible
BALM, indicating extreme eveningness. Thus, the few
heterozygotes were heterogeneous in BALM morningness-
eveningness. These polymorphisms have been submitted to
NCBI as nucleotides 27740 and 28266 in Core Nucleotide
Report EF015901 (available at http://www.ncbi.nlm.nih.
gov/entrez/viewer.fcgi?db=nuccore&id=121647019).
Unipolar major depression sib pairs
There were 89 sib pairs concordant for unipolar major
depressive disorder and 60 discordant sib pairs with one
twin having no mental illness. They were genotyped
for 61 SNPs which proved sufficiently heterozygous
and one repeat region in PER3.O ft h e s e ,2r e a c h e d
nominal significance (Table 3). In the promoter region
of TEF, rs738499 was associated with MDD by sib-TDT
with P = 0.012. The minor G allele was protective. Also,
rs7732671 in PPARGC1B was associated with P = 0.023,
with the minor allele being associated with depression.
Neither SNP was significant after correction for multiple
comparison (EMP2) [see Additional file 3].
Sleep clinic patients
Many Sleep Clinic patients report some degree of depres-
sion. Their QIDS-SR averaged 6.9 (in the mildly depressed
range) with SD 3.9. Also, 16.2% scored ≥ 10, in the
moderately depressed range. In an attempt to replicate
results from other subject groups, 2 SNPs were examined:
rs738499 and rs2314339. The number of the less-common
G alleles in the TEF T>G SNP rs738499 was correlated with
the QIDS-SR, Rs = -0.165 (P = 0.001, Spearman Rank Order
Correlation). The negative correlation suggests that the G
allele was associated with normal mood and might account
for about 3% of the variance. Neither rs738499 nor
rs2314339 were correlated with the BALM nor was
rs2314339 correlated with the QIDS-SR.
Discussion
In four different analyses, circadian gene polymorphisms
were studied for association with three phenotypes: bipolar
disorder, unipolar depression (major depressive diagnosis
or rating-scale quantitative trait), and morningness-even-
ingness (which shares comorbidity with major depression)
[19]. In 294 tests of association, 23 different associations
met the nominal significance criterion of P < 0.05, whereas
15 such associations would have been anticipated by
random chance. It is plausible that most of the nominal
associations were due to random chance (false discovery),
but at least 5 appeared associated with these affective
phenotypes with sufficient evidence of reliability to be
considered suggestive.
The intronic SNP rs2314339 in NR1D1 met false discovery
and empirical family-wise criteria for significant association
with the transmission of bipolar disorder (P = 0.0005). The
TDT analysis should be free from biases due to racial
stratification. The same SNP was associated with delayed
sleep phase disorder cases in an unpublished case-control
sample, but significance was not sustained in the case-
control sample after preliminary control for racial stratifica-
tion. In both analyses, the more common allele was
associated with the disorder and the less common allele
was associated with control or normal health. The DSPD
data offered at best only an indirect kind of replication
because of the difference in phenotype between bipolar
disorderandDSPD,especiallyconsideringthatinourDSPD
sample, we had found comorbidity with unipolar depres-
sion but not with bipolar disorder [19]. Moreover,
rs2314339 has been tested in some whole genome
association studies of bipolar disorder, but we are unaware
that any suggestive association has been found in such
Table 3: SNPs associated with unipolar recurrent major depression
Gene CHR SNP A1 A2 MAF OBS EXP EMP1 EMP2
PPARGC1B 5 rs7732671 C G 0.092 14 10 0.0232 0.3148
TEF 22 rs738499 G T 0.334 35 41.5 0.0114 0.2123
CHR: chromosome. A1 & A2: minor and major allele nucleotides. MAF: minor allele frequency. OBS: number of observed minor alleles. Exp: number
of expected minor alleles. EMP1: pointwise empirical P value. EMP2: corrected empirical P value from max/(T)/familywise.
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tobeassociatedwithbipolardisorderinacase-controlstudy
[38]: there has been brief mention that NR2E1 and NR1D1
may interact in the development of photoreceptors.
NR1D1 (OMIM 602408) is a key element of a unique
circadian feedback loop, in which it inhibits transcrip-
tion of ARNTL ( B M A L 1 )b yi n h i b i t o r yb i n d i n ga tARNTL
RORE promoter sites [39]. NR1D1 may similarly inhibit
transcription of CLOCK and NPAS2, the proteins of
which activate ARNTL by binding as heterodimers.
NR1D2 possibly has a similar role (OMIM 602304).
These mechanisms may be particularly relevant to
bipolar disorder, since it has been suggested that a
mutation of CLOCK (which produces hyperactivity) may
be an animal model for bipolar mania [40]. A knockout
of ARNTL, on the other hand, reduces activity, though
that can be largely restored by replacing ARNTL function
in muscle [41]. ARNTL heterodimers with NPAS2 may
bind to promoter eboxes of MAOA, thus promoting
inactivation of dopamine, and thus inhibiting the pro-
manic effects of dopamine [42-44]. Oddly enough, the
ARNTL-CLOCK heterodimer was not demonstrated to
have a similar effect on MAOA, though ARNTL-CLOCK
would be expected to act on the same e-boxes in the
MAOA promoter. Lithium, a primary medication for
treatment of bipolar disorder, promotes degradation of
NR1D1 through inhibition of GSK3, whereas GSK3
phosphorylation stabilizes NR1D1 [45]. These interac-
tions are modeled in Fig. 1.
NR1D1 or Rev-erb-alpha is so-called, because it is tran-
scribed in the reverse direction and overlaps the 3' end of
THRA, an important thyroid nuclear receptor. It is interest-
ing that thyroid dysfunction becomes most prominent
among bipolar patients after treatment with lithium [46].
Also, thyroid (T3) augmentation is useful for treating
depression [47]. Thyroid has been used for periodic
catatonia (perhaps a form of bipolar disorder) since the
1930's [1]. Considering that the intronic location of
rs2314339 indicates no obvious functional role, we suspect
that this SNP might be in linkage disequilibrium with some
nearby polymorphism with a key functional effect. As
linkagedisequilibriumforrs2314339extendsthroughmost
ofNR1D1andtothe3'endofTHRA,thefunctionalelement
could plausibly be situated in either gene.
Ac o d i n gS N Pi nPPARGC1B, Pro203Ala, rs7732671, was
over-transmitted to bipolar probands with P < 0.05 and
odds ratio 1.55. By itself, we might regard this isolated
finding as statistically unimpressive and plausibly a false
positive. However, the same SNP was associated with
unipolar depression with an odds ratio of 2.12 (P < 0.025).
The nominally significant association in both completely
separate subject sets with odds ratios in the same direction
provides suggestive evidence for a reliable association,
especially since neither statistical result is sensitive to false
positiveresultsfrompopulationstratification.Thecommon
allele of this SNP has been associated with obesity (OMIM
608886). A paralogue gene, PPARGC1A, is a regulator of
ARNTL and additionally functions through regulation of
NR1D1 and NR1D2 effects on ARNTL [48]. PPARGC1A
possibly binds to RORE sites both on NR1D1 and on
ARNTL, and PPARGC1B may act similarly, perhaps provid-
ing a partial explanation for effects on both mania and
depression, seeming opposites which are both aspects of
bipolar disorder (Fig. 1). Thus, there may be a convergence
of pathways. A number of SNPs in PPARGC1B achieved
nominalsignificance inacase-controlstudywhichincluded
some of these same bipolar subjects, but none approached
Bonferroni criteria [22].
The TDT association of 6 CLOCK SNPs with bipolar
disorder was intriguing, and appeared consistent with
Figure 1
Model relating sunlight, lithium, and circadian genes
to MAOA and mania. This model relates sunlight and
lithium to components of the circadian gene system, to
MAOA (monoamine oxidase A), dopamine, and resultant
stimulation of mania. Green solid arrows represent
interactions which promote the function of the affected
component. Red striped arrows represent inhibition of the
function of the affected component. Components in white
boxes hypothetically promote mania. Components in black
boxes hypothetically inhibit mania. The red-green striped
box for PPARGC1B suggests its opposing roles in possibly
stimulating both ARNTL and NR1D1, whereas NR1D1 then
inhibits ARNTL. The positive feedback of ARNTL-CLOCK
and ARNTL-NPAS2 heterodimers on NR1D1, TEF, PER1,
PER2, and PER3 was omitted from the diagram for simplicity,
along with many other components and interactions within
the circadian system.
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mouse analog of mania [40]. Although nominally
significant, associations with these SNPs could all
represent false-positive statistical findings. One of the 6
SNPs, rs6850524 was also found to be suggestively
associated with bipolar disorder in analyses using a
partially-overlapping subject sample [17]. Also, CLOCK
SNP rs2412648 (P < 0.05 by Chi Square, P > 0.05 by
EMP1 in our sample) was part of a suggestively-
associated haplotype [17]. It would be conceivable that
many SNPs in the CLOCK gene, each with a small effect
impairing the gene, could in combination make a
substantial contribution of bipolar susceptibility.
Because the CLOCK gene, extending over roughly
114,338 base pairs, displays high linkage disequilibrium
throughout its considerable length, it is possible that the
most functional polymorphism has not yet been
recognized. Similarly, though various associations with
several bipolar phenotypes such as recurrence rates and
sleep disturbances have been reported with rs1801260,
the T3111C SNP in the 3'UTR region of CLOCK [36, 37],
it is possible that rs1801260 is not the most functional
polymorphism in linkage disequilibrium. In our TDT
analysis and in BALM studies, rs1801260 was not
associated with bipolar disorder, nor was it associated
with the morningness-eveningness dimension, as had
been reported in other data [36].
In 1978, at a time when the gene causing the Drosophila
PER mutant had not yet been identified and the presence
of 3 human homologues was unknown, the first author
hypothesized that bipolar disorder might be caused by
mutation of a homologue of the PER gene [49]. The
three SNPs in PER2 and rs2585405 in PER1,w h i c hw e r e
over-transmitted or under-transmitted to bipolar pro-
bands with nominal significance, gave weak support to
this archaic hypothesis, but certainly suggested no major
role for the PER genes in bipolar disorder. On the other
hand, associations of affective symptoms with other
polymorphisms provided some of the strongest evidence
that the circadian system has a role in affective disorders.
T h el a c ko fc o n s i s t e n c yi nr e s u l t sf o rt h ePER homo-
logues in different groups was somewhat disappointing
and reminds us that these associations may be false
positive results. It would appear that additional large
and independent samples must be studied to determine
if the PER genes have a real role in human affective
disorders. Bright light, which promotes mania, tends to
promote transcription of the PER1 and PER2 genes [50],
which may then inhibit the action of the ARNTL-NPAS2
heterodimer in stimulating MAOA (Fig. 1). Thus, this
pathway may also be consistent with our model in Fig. 1.
However, the model ignores numerous problems and
complexities of circadian regulation and fails to incor-
porate the dynamic circadian fluctuations or the
photoperiodic interactions among circadian system
components. We also have not explained how the
observed differences in genetic background might
produce the distinctive phenotypes among patients
with unipolar and bipolar disorders, nor have we
suggested the mechanism by which the same genetic
background creates susceptibility in bipolar patients to
both mania and depression.
The TEF promoter SNP rs738499 had a statistically
unimpressive (Pnominal = 0.023) association with uni-
polar recurrent depression, with the less common G
allele being associated with healthy mood. A similar
association with the QIDS-SR in the Sleep Center sample
provided a degree of replication (P < 0.001), using
independent subjects, independent methods, and a
different lab and assay procedure. We had selected
rs738499 for genotyping based on a report that
rs5996091, a SNP over 500,000 nucleotides remote
from TEF, was highly correlated with TEF expression
with R
2 = 0.43 [51], and we had noted that of HapMap
SNPs nearer TEF, rs738499 had the highest linkage with
rs5996091 as well as a likely location in the promoter.
By stimulatory binding at D-box promoter sites, TEF may
promote transcription of NR1D1, NR1D2,a n dt h ePER
genes, actions which might be supposed to stimulate
mania or counter depression (Fig. 1). However, we do
not know if the rs738499 minor allele promotes or
inhibits TEF transcription.
Two intronic SNPs in CSNK1E were associated with the
BALM among bipolar subjects, meeting Bonferroni
criteria for significance. The two SNPs were in virtually
perfect linkage disequilibrium with each other. However,
among 26 SNPs in CSNK1E identified by resequencing
12,173 nucleotides of exonic, intronic, and promoter
regions of the gene, no other SNPs were found to be in
substantial linkage disequilibrium with these two SNPs
(see Core Nucleotide Report EF015901). Surprisingly,
although 4 of the 6 participants from the bipolar sample
with these two SNPs displayed extreme morningness,
one subject of the 6 had a score at the opposite end of
the morningness-eveningness scale. Both SNPs were
under-transmitted to bipolars (NS). CSNK1E phosphor-
ylates several of the circadian proteins including the PER
proteins and ARNTL, and may even have differential
effects on phase adjustment depending on which
phosphorylation sites are intact on various substrates
[52, 53]. CSNK1D has a somewhat similar role. Note
that one CSNK1D SNP was nominally associated with
bipolar disorder, and the CSNK1D region on 17q
achieved a maximum LOD score of 3.63 in a bipolar
association study [54]. However, since the two CSNK1E
SNPs and the PER3 SNP associated with the BALM scale
of morningness-eveningness were not associated with
Journal of Circadian Rhythms 2009, 7:2 http://www.jcircadianrhythms.com/content/7/1/2
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seems that the circadian polymorphisms which are
related to affective disorders do not influence affective
state simply through effects on circadian phase, e.g.,
Fig. 1 does not suggest that the effects are mediated
through circadian phase change.
It is important to review some suggestive findings
reported elsewhere which were not replicated in these
analyses. We were not able to confirm the suggestive
evidence we had earlier reported that haplotypes in
ARNTL and PER3 were associated with bipolar disorder
[15]. Those haplotype associations had previously fallen
short of Bonferroni criteria. We have also examined
certain candidates for association proposed by Mansour
and colleagues [13, 16]. These included rs7107287,
rs4757142, and rs1982350 in ARNTL, rs2859387 in
PER3, and rs2291738 and rs2279665 in TIMELESS.
None of these reached nominal significance of P < 0.05
in our TDT analyses. The rs11541353 SNP in NPAS2 and
rs2290035 in ARNTL,r e p o r t e dt ob ea s s o c i a t e dw i t h
seasonal affective disorder [55, 56], were not signifi-
cantly associated with bipolar disorder in our families by
TDT. In PER3, rs10462020 was not associated with
bipolar disorder or unipolar depression. Also, we have
not yet demonstrated any association of the PER3 repeat
described by Archer et al. with affective disorders [26].
Conclusion
In summary, we found several suggestive associations of
circadian gene polymorphisms with affective disorders,
some of which we were able to partially replicate. The
association of NR1D1 rs2314339 with bipolar disorder
and DSPS and the association of PPARGC1B Pro203Ala,
rs7732671, with both bipolar and unipolar affective
disorders appear the most likely to prove reliable. The
association of TEF rs738499 with unipolar depression
may also prove reliable. Two intronic SNPs in CSNK1E
were associated with the BALM in bipolars, but the
inconsistent directions of association stimulate some
reserve, and these SNPs were not directly associated with
affective diagnoses or symptoms. Each of these leads
should be pursued. When genotyping of ancestry-
informative markers becomes available, our correlations
of the BALM with genotypes should be controlled for
population stratification, which is a potential problem in
the Sleep Center sample as well. Replication and
extension of these results in larger independent samples
is needed before the importance of circadian poly-
morphisms in affective syndromes can be verified. If the
findings are confirmed, they will suggest that bipolar and
unipolar affective disorders have at least one common
genetic susceptibility factor, but several which are
distinct.
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